Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes

The safety and efficacy of anti-diabetic drugs are critical for maximizing the beneficial impacts of well-controlled blood glucose on the prognosis of individuals with COVID-19 and pre-existing type 2 diabetes (T2D). Metformin is the most commonly prescribed first-line medication for T2D, but its im...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xu, Liu, Ye-Mao, Li, Haomiao, Zhang, Xin, Lei, Fang, Qin, Juan-Juan, Chen, Ze, Deng, Ke-Qiong, Lin, Lijin, Chen, Ming-Ming, Song, Xiaohui, Xia, Meng, Huang, Xuewei, Liu, Weifang, Cai, Jingjing, Zhang, Xiao-Jing, Zhou, Feng, Zhang, Peng, Wang, Yibin, Ma, Xinliang, Xu, Qingbo, Yang, Juan, Ye, Ping, Mao, Weiming, Huang, Xiaodong, Xia, Jiahong, Zhang, Bing-Hong, Guo, Jiao, Zhu, Lihua, Lu, Zhibing, Yuan, Yufeng, Wei, Xiang, She, Zhi-Gang, Ji, Yan-Xiao, Li, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Clinical and Translational Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7439986/
https://www.ncbi.nlm.nih.gov/pubmed/32861268
http://dx.doi.org/10.1016/j.cmet.2020.08.013

Ejemplares similares

Ejemplares similares